(+)‐3,6‐Epoxymaaliane: A Novel Derivative of (+)‐Bicyclogermacrene Oxidation Catalyzed by CYP450 BM3‐139‐3 and Its Variants
ChemBioChem · 2024
DOI: 10.1002/cbic.202400410 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Kai Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and T…. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Bacillus megaterium, Oxidation-Reduction, Sesquiterpenes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
(+)‐Bicyclogermacrene is a sesquiterpene compound found in various plant essential oils and serves as a crucial precursor for multiple biologically active compounds. Many derivatives of (+)‐bicyclogermacrene have been shown to exhibit valuable bioactivities. Cytochrome P450 BM3 from Bacillus megaterium can catalyze a variety of substrates and different types of oxidation reactions, making it become a powerful tool for oxidizing terpenes. In this study, we employed P450 BM3‐139‐3 variant for in vitro enzymatic oxidation of (+)‐bicyclogermacrene, identifying a novel oxidized derivative of (+)‐bicyclogermacrene, named (+)‐3,6‐epoxymaaliane, and an unknown sesquiterpenoid in a ratio of 70 : 30 (by GC peak area). (+)‐3,6‐Epoxymaaliane showed demonstrated antibacterial activities toward Escherichia coli and Staphylococcus aureus . To obtain a better variant of the monooxygenase with a high selectivity to form (+)‐3,6‐epoxymaaliane, we combined alanine scanning with the “Focused Rational Iterative Site‐Specific Mutagenesis” (FRISM) strategy to modify the closest residues within 5 Å radius surrounding the substrate to create a small‐but‐smart library of mutants. Consequently, it gave an optimal variant with 1.6‐fold improvement, in a turnover number (TON) of up to 964 toward (+)‐3,6‐epoxymaaliane production with a higher product selectivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.
ORCID-Profile: Jian-He Xu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Xu, K., Huang, Z. Y., Sun, C. Y., Pan, J., Li, C. X., & Xu, J. H. (2024). (+)‐3,6‐Epoxymaaliane: A Novel Derivative of (+)‐Bicyclogermacrene Oxidation Catalyzed by CYP450 BM3‐139‐3 and Its Variants. ChemBioChem. https://doi.org/10.1002/cbic.202400410
Vancouver
Xu K, Huang ZY, Sun CY, Pan J, Li CX, Xu JH. (+)‐3,6‐Epoxymaaliane: A Novel Derivative of (+)‐Bicyclogermacrene Oxidation Catalyzed by CYP450 BM3‐139‐3 and Its Variants. ChemBioChem. 2024. doi:10.1002/cbic.202400410
BibTeX
@article{Xu2024,
author = {Xu, Kai and Huang, Zheng-Yu and Sun, Chen-Yi and Pan, Jiang and Li, Chun-Xiu and Xu, Jian-He},
title = {(+)‐3,6‐Epoxymaaliane: A Novel Derivative of (+)‐Bicyclogermacrene Oxidation Catalyzed by CYP450 BM3‐139‐3 and Its Variants},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400410}
}
EUVIMED